Clinical Trial

Expand Management of Blood Pressure With Renal Denervation in Patients Undergoing Staged PCI for Advanced Coronary Artery diseasE

Name: Expand Management of Blood Pressure With Renal Denervation in Patients Undergoing Staged PCI for Advanced Coronary Artery diseasE — clinical trial record (NCT07602790)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Study acronym: EMBRACE

Not Yet Recruiting

View on ClinicalTrials.gov →

Summary

EMBRACE is a randomized, controlled, multicenter clinical study evaluating the effect of renal denervation on clinical adverse events in hypertensive patients undergoing staged percutaneous coronary intervention (PCI) for multivessel coronary artery disease.

Trial Details

NCT Number	NCT07602790
Lead Sponsor	Ceric Sàrl
Conditions	Multivessel Coronary Artery Disease, Hypertension Resistant to Conventional Therapy
Enrollment	1,000 participants
Start Date	2026-11
Primary Completion	2030-11 (estimated)
Study Completion	2033-11 (estimated)
Updated on ClinicalTrials.gov	2026-05-22